Menu

Image of American Hospital Association letter to HRSA Administrator Thomas J. Engels

AHA again urged HRSA on Monday to address what it called “unlawful” drugmaker policies that require 340B covered entities to report 340B claims data for in-house pharmacy utilization following new reported threats from Eli Lilly.

Hospital Group Again Asks HRSA to Address Drugmakers’ 340B In-House Pharmacy Claims Data Requirements

April 28, 2026 Shannon Young, Managing Editor 340B Report Views

A key hospital trade group again urged the Health Resources and Services Administration (HRSA) on Monday to address what it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

340B Lobbying Held Steady in First Quarter of 2026, Filings Show

UPDATED: GOP Lawmakers Accuse Urban Hospitals of Misusing 340B Program at U.S. House Hearing